Q1 2023 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the quarter ended March 31, 2023, and to provide a general business update. This call is being recorded. My name is Mallory, and I will be your operator today.
With us today are Sabrina Martucci Johnson, Daré President and Chief Executive Officer; John Fair, Daré's Chief Commercial Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer.
Ms. Johnson, please proceed.
© -
Thank you. Good afternoon and welcome to the financial results and business update call for the quarter ended March 31, 2023, for Daré Bioscience. Our plan today is to review our first-quarter results, discuss development since our recent call on March, and highlight some important objectives and milestones anticipated in 2023.
Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |